Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (721-730 of 777) with videos related to

Pageof 78
Sort By:
Translational Psychiatry|July 25, 2022
Polygenic resilience scores capture protective genetic effects for Alzheimer's diseaseJiahui Hou, Jonathan L Hess, Nicola Armstrong, et al.
Nature Medicine|March 13, 2020
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseNicolas R Barthélemy, Yan Li, Nelly Joseph-Mathurin, et al.
Brain Informatics|January 27, 2025
Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2021
Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in SydneyClaire E Sexton, Kaarin J Anstey, Filippo Baldacci, et al.
The Lancet. Neurology|July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional studyAnne M Fagan, Rachel L Henson, Yan Li, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort StudiesRalph N Martins, Victor Villemagne, Hamid R Sohrabi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 6, 2014
Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosisBlaine R Roberts, Nastasia K H Lim, Erin J McAllum, et al.
Epidemiology (Cambridge, Mass.)|March 31, 2025
Approaches to Timescale Choice in Cognitive Aging Research and Potential Implications for Estimated Exposure Effects: Coordinated Analyses in 10 Cohorts of Older AdultsEleanor Hayes-Larson, Ryan M Andrews, Katrina L Kezios, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Rethinking the residual approach: Leveraging machine learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Brain Communications|May 24, 2024
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's diseaseLeonardo Iaccarino, Jorge J Llibre-Guerra, Eric McDade, et al.
Pageof 78

Showing results (721-730 of 777) with videos related to

Sort By:
Pageof 78
Translational Psychiatry|July 25, 2022
Polygenic resilience scores capture protective genetic effects for Alzheimer's diseaseJiahui Hou, Jonathan L Hess, Nicola Armstrong, et al.
Nature Medicine|March 13, 2020
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseNicolas R Barthélemy, Yan Li, Nelly Joseph-Mathurin, et al.
Brain Informatics|January 27, 2025
Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2021
Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in SydneyClaire E Sexton, Kaarin J Anstey, Filippo Baldacci, et al.
The Lancet. Neurology|July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional studyAnne M Fagan, Rachel L Henson, Yan Li, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort StudiesRalph N Martins, Victor Villemagne, Hamid R Sohrabi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 6, 2014
Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosisBlaine R Roberts, Nastasia K H Lim, Erin J McAllum, et al.
Epidemiology (Cambridge, Mass.)|March 31, 2025
Approaches to Timescale Choice in Cognitive Aging Research and Potential Implications for Estimated Exposure Effects: Coordinated Analyses in 10 Cohorts of Older AdultsEleanor Hayes-Larson, Ryan M Andrews, Katrina L Kezios, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Rethinking the residual approach: Leveraging machine learning to operationalize cognitive resilience in Alzheimer's diseaseColin Birkenbihl, Madison Cuppels, Rory T Boyle, et al.
Brain Communications|May 24, 2024
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's diseaseLeonardo Iaccarino, Jorge J Llibre-Guerra, Eric McDade, et al.
Pageof 78